President Trump has inherited an evolving chemical and biological threat landscape, but not one he hasn’t encountered before. Trump struck Bashar al-Assad’s airbases in 2017 and 2018, after the ...

There are no better proving grounds than the streets of New York City. It’s where dreams meet steel and concrete, where ...

India needs to grow at 8 percent for up to two decades to become a developed nation by 2047, the Economic Survey said on ...

Fate Therapeutics, Inc. (NASDAQ:FATE), a clinical-stage biopharmaceutical company with a market capitalization of $156.6 million, is at a pivotal juncture in its development of programmed cellular ...

A graduate of Stanford University's prestigious EENT Innovation Biodesign program in 2019, Diag-Nose.io is redefining ...

We recently compiled a list of the 12 Stocks That Will Double in 2025. In this article, we are going to take a look at where ...

CES 2025, the largest tech event in the world, welcomed over 141,000 attendees from around the globe – eager to share and ...

The Warren-headquartered clinical-stage specialty immunotherapy biotechnology company focuses on the development of T-cell ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning, today we look at ...

Wafaa Mamilli will join Roche as the company's new Chief Digital Technology Officer in February. This follows expansive roles she has held at Zoetis and at Eli Lilly.

Tech stock plunge due to DeepSeek's AI app news is a minor market correction. Explore more details here.

L'Oréal -backed biotech firm Debut has released an artificial intelligence (AI)-powered ingredient discovery platform aimed at the beauty industry. BeautyORB works to discover novel ingredients and ...